- Report
- August 2025
- 180 Pages
Global
From €3910EUR$4,500USD£3,409GBP
- Report
- April 2025
- 184 Pages
Global
From €3910EUR$4,500USD£3,409GBP
- Report
- February 2025
- 185 Pages
Global
From €3910EUR$4,500USD£3,409GBP
- Report
- February 2026
- 271 Pages
Global
From €5083EUR$5,850USD£4,432GBP
- Report
- February 2026
- 381 Pages
Global
From €5083EUR$5,850USD£4,432GBP
- Report
- February 2026
- 272 Pages
Global
From €5083EUR$5,850USD£4,432GBP
- Report
- February 2026
- 193 Pages
Global
From €5083EUR$5,850USD£4,432GBP
- Report
- February 2026
- 131 Pages
Global
From €5083EUR$5,850USD£4,432GBP
- Report
- February 2026
- 276 Pages
Global
From €5083EUR$5,850USD£4,432GBP
- Report
- February 2026
- 258 Pages
Global
From €5083EUR$5,850USD£4,432GBP
- Report
- May 2025
- 106 Pages
Global
From €4128EUR$4,750USD£3,598GBP
- Report
- October 2025
- 144 Pages
Global
From €3475EUR$3,999USD£3,029GBP
- Report
- November 2025
- 150 Pages
Global
From €3259EUR$3,750USD£2,841GBP
- Report
- July 2025
- 350 Pages
Global
From €4300EUR$4,949USD£3,749GBP
- Report
- June 2025
- 400 Pages
Global
From €4300EUR$4,949USD£3,749GBP
- Report
- June 2025
- 150 Pages
Global
From €2345EUR$2,699USD£2,045GBP
- Report
- June 2025
- 150 Pages
Global
From €2345EUR$2,699USD£2,045GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2424EUR$2,789USD£2,113GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2424EUR$2,789USD£2,113GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2424EUR$2,789USD£2,113GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more